Diverting Ileostomy and Transverse Colostomy Comparative Study
Diverting Ileostomy Verses Transverse Colostomy in Colorectal Surgery
1 other identifier
interventional
36
0 countries
N/A
Brief Summary
Protective diverting stomas are frequently constructed after low anterior resection or colorectal anastomosis to mitigate the consequences of anastomotic leakage, one of the most feared complications in colorectal surgery. Both loop ileostomy (LI) and loop transverse colostomy (TC) are accepted methods of diversion. Randomized and observational studies have shown that faecal diversion significantly reduces the clinical severity of leaks and the need for reoperation compared with no diversion. The choice between LI and TC remains controversial. Loop ileostomy is technically straightforward and associated with shorter operative time and fewer septic complications at closure. However, it carries specific risks, including high-output stoma, dehydration, electrolyte imbalance, and renal impairment, which may lead to hospital readmissions. Conversely, loop transverse colostomy is associated with fewer fluid and electrolyte issues, but has higher rates of prolapse, skin irritation, and wound complications at closure. Meta-analyses comparing LI and TC indicate no clear superiority, with each approach demonstrating distinct patterns of morbidity. Some randomized trials have suggested lower major morbidity with LI, while others found no significant difference. Given the heterogeneity of outcomes and limited high-quality, adequately powered trials, further randomized evidence is needed to guide optimal stoma selection in colorectal surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
December 16, 2025
CompletedStudy Start
First participant enrolled
January 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2027
December 16, 2025
November 1, 2025
1.4 years
November 20, 2025
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of Participants With Clinically or Radiologically Confirmed Anastomotic Leak
Count of participants in each arm who develop an anastomotic leak confirmed by clinical signs (such as fever, abdominal pain, peritonitis, or purulent discharge) and/or by contrast-enhanced radiological imaging. The unit of measure will be number of participants.
From index colorectal surgery to 30 days after surgery
Severity of Anastomotic Leak Assessed by Clavien-Dindo Classification
Distribution of Clavien-Dindo complication grades among participants who develop an anastomotic leak in each arm. The unit of measure will be number of participants in each Clavien-Dindo grade category.
From index colorectal surgery to 30 days after surgery
Number of Participants With Anastomotic Leak Requiring Surgical Management
Count of participants with anastomotic leak who require operative intervention, including re-laparotomy, laparoscopic washout, stoma revision, or creation of a new stoma. The unit of measure will be number of participants.
From index colorectal surgery to 30 days after surgery
Secondary Outcomes (4)
Intraoperative Blood Loss During Index Surgery
Intraoperative period of index surgery
Number of Participants With Postoperative Bleeding Requiring Transfusion or Intervention
From index colorectal surgery to 30 days after surgery
Operative Time for Index Surgery
Intraoperative period of index surgery
Length of Hospital Stay After Index Surgery
Baseline
Study Arms (2)
diverting ileostomy
ACTIVE COMPARATORtransverse colostomy
ACTIVE COMPARATORInterventions
a surgical procedure in which the a segment of the ileum is mobilized and placed as a stoma diverting technique to protect any distal anastomosis
a surgical procedure in which the a segment of the transverse colon is mobilized and placed as a stoma diverting technique to protect any distal anastomosis.
Eligibility Criteria
You may qualify if:
- Adults ≥18 years undergoing elective low anterior resection or coloanal anastomosis for benign or malignant colorectal disease.
- Patients for whom the surgeon has decided that a diverting stoma is required such as emergency resection and anastomosis cases where a covering stoma is indicated.
- Ability to provide informed consent.
You may not qualify if:
- Patients with pre-existing stoma.
- Severe comorbidities precluding stoma creation (e.g., advanced renal failure, uncontrolled cardiac disease).
- Patients with extensive peritoneal carcinomatosis or unresectable disease.
- Pregnant or lactating women.
- Inability to comply with follow-up or provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Mohamed H Othman, Doctorate
Assiut University
- STUDY DIRECTOR
Mohamed abulfetouh, Doctorate
Assiut University
- STUDY DIRECTOR
Ahmed G Hemdan, doctorate
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident at the Department of General Surgery, Assiut University
Study Record Dates
First Submitted
November 20, 2025
First Posted
December 16, 2025
Study Start
January 30, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
November 30, 2027
Last Updated
December 16, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
age, brief medical and surgical history , lab investigations and any imaging done pre or post operative